Fig. 5: Impact of Anti-VEGF treatment on the spatial distribution of oxygen concentration and viable cancer cells.

The spatial distribution of oxygen concentration [mole/m³] and viable cancer cells (volume fraction) for control and anti-VEGF on day 16 of the simulation.